Advertisement
Screener

Kronos Bio, Inc. Share-based Payment Arrangement, Expense

Kronos Bio, Inc. Share-based Payment Arrangement, Expense

Kronos Bio, Inc. reported Share-based Payment Arrangement, Expense of $604.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-08.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-05-08

  • Kronos Bio, Inc. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $604.00K, a 92.16% decline year-over-year.
  • Kronos Bio, Inc. share-based payment arrangement, expense for the quarter ending 2024-12-31 was $2.20M, a 57.51% decline year-over-year.
  • Kronos Bio, Inc. share-based payment arrangement, expense for the quarter ending 2024-09-30 was $2.03M, a 67.76% decline year-over-year.
  • Kronos Bio, Inc. share-based payment arrangement, expense for the quarter ending 2024-06-30 was $2.20M, a 68.10% decline year-over-year.
  • Kronos Bio, Inc. share-based payment arrangement, expense for fiscal 2024 was $14.14M, a 43.41% decline from fiscal 2023.
  • Kronos Bio, Inc. share-based payment arrangement, expense for fiscal 2023 was $24.98M, a 19.79% decline from fiscal 2022.
  • Kronos Bio, Inc. share-based payment arrangement, expense for fiscal 2022 was $31.14M, a 18.82% increase from fiscal 2021.
  • Kronos Bio, Inc. share-based payment arrangement, expense for fiscal 2021 was $26.21M, a 598.40% increase from fiscal 2020.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 3 month as first filedShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 month
2025-03-31$604.00K
10-Q · filed 2025-05-08
$2.80M
derived: sum of 2 quarters · filed 2025-05-08
$4.83M
derived: sum of 3 quarters · filed 2025-05-08
$7.04M
derived: sum of 4 quarters · filed 2025-05-08
2024-12-31$2.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
$4.23M
derived: sum of 2 quarters · filed 2025-03-18
$6.43M
derived: sum of 3 quarters · filed 2025-03-18
$14.14M
10-K · filed 2025-03-18
2024-09-30$2.03M
10-Q · filed 2024-11-13
$4.23M
derived: sum of 2 quarters · filed 2024-11-13
$11.94M
10-Q · filed 2024-11-13
$17.11M
derived: sum of 4 quarters · filed 2025-05-08
2024-06-30$2.20M
10-Q · filed 2024-08-08
$9.91M
10-Q · filed 2024-08-08
$15.08M
derived: sum of 3 quarters · filed 2025-05-08
$21.38M
derived: sum of 4 quarters · filed 2025-05-08
2024-03-31$7.71M
10-Q · filed 2025-05-08
$12.88M
derived: sum of 2 quarters · filed 2025-05-08
$19.18M
derived: sum of 3 quarters · filed 2025-05-08
$26.08M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$5.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18
$11.47M
derived: sum of 2 quarters · filed 2025-03-18
$18.38M
derived: sum of 3 quarters · filed 2025-03-18
$24.98M
10-K · filed 2025-03-18
2023-09-30$6.30M
10-Q · filed 2024-11-13
$13.20M
derived: sum of 2 quarters · filed 2024-11-13
$19.81M
10-Q · filed 2024-11-13
$27.50M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$6.91M
10-Q · filed 2024-08-08
$13.51M
10-Q · filed 2024-08-08
$21.20M
derived: sum of 3 quarters · filed 2024-08-08
$28.66M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$6.61M
10-Q · filed 2024-05-09
$14.30M
derived: sum of 2 quarters · filed 2024-05-09
$21.76M
derived: sum of 3 quarters · filed 2024-05-09
$29.96M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$7.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21
$15.15M
derived: sum of 2 quarters · filed 2024-03-21
$23.36M
derived: sum of 3 quarters · filed 2024-03-21
$31.14M
10-K · filed 2024-03-21
2022-09-30$7.46M
10-Q · filed 2023-11-13
$15.67M
derived: sum of 2 quarters · filed 2023-11-13
$23.46M
10-Q · filed 2023-11-13
$30.86M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$8.21M
10-Q · filed 2023-08-08
$15.99M
10-Q · filed 2023-08-08
$23.40M
derived: sum of 3 quarters · filed 2023-08-08
$30.54M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31$7.79M
10-Q · filed 2023-05-10
$15.19M
derived: sum of 2 quarters · filed 2023-05-10
$22.33M
derived: sum of 3 quarters · filed 2023-05-10
$28.76M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$7.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15
$14.54M
derived: sum of 2 quarters · filed 2023-03-15
$20.97M
derived: sum of 3 quarters · filed 2023-03-15
$26.21M
10-K · filed 2023-03-15
2021-09-30$7.14M
10-Q · filed 2022-11-08
$13.57M
derived: sum of 2 quarters · filed 2022-11-08
$18.81M
10-Q · filed 2022-11-08
$20.83M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30$6.43M
10-Q · filed 2022-08-04
$11.67M
10-Q · filed 2022-08-04
$13.69M
derived: sum of 3 quarters · filed 2022-08-04
$14.94M
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31$5.24M
10-Q · filed 2022-05-04
$7.26M
derived: sum of 2 quarters · filed 2022-05-04
$8.51M
derived: sum of 3 quarters · filed 2022-05-04
$8.80M
derived: sum of 4 quarters · filed 2022-05-04
2020-12-31$2.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$3.27M
derived: sum of 2 quarters · filed 2022-02-24
$3.57M
derived: sum of 3 quarters · filed 2022-02-24
$3.75M
10-K · filed 2022-02-24
2020-09-30$1.25M
10-Q · filed 2021-11-09
$1.25M
10-Q · filed 2020-11-18
$1.55M
derived: sum of 2 quarters · filed 2021-11-09
$1.73M
10-Q · filed 2021-11-09
$1.79M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$293.00K
10-Q · filed 2021-08-12
$481.00K
10-Q · filed 2021-08-12
$534.00K
derived: sum of 3 quarters · filed 2022-02-24
$557.00K
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$188.00K
10-Q · filed 2021-05-11
$241.00K
derived: sum of 2 quarters · filed 2022-02-24
$264.00K
derived: sum of 3 quarters · filed 2022-02-24
2019-12-31$53.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$76.00K
derived: sum of 2 quarters · filed 2022-02-24
$113.00K
10-K · filed 2022-02-24
2019-09-30$23.00K
10-Q · filed 2020-11-18
$60.00K
10-Q · filed 2020-11-18
2018-12-31$30.00K
10-K · filed 2021-03-23